You have 9 free searches left this month | for more free features.

Leukemia, Mast-Cell

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Aggressive Systemic Mastocytosis, Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease, Mast Cell Leukemia Trial

Completed
  • Aggressive Systemic Mastocytosis
  • +3 more
  • Stanford, California
  • +10 more
Jan 12, 2023

High-risk MDS, Acute Myelogenous Leukemia, Systemic Mastocytosis Trial in Minneapolis, Madison (GTB-3550 TriKE® Phase I,

Terminated
  • High-risk Myelodysplastic Syndromes
  • +3 more
  • GTB-3550 TriKE® Phase I
  • GTB-3550 TriKE® Phase II
  • Minneapolis, Minnesota
  • +1 more
Mar 21, 2022

Advanced Systemic Mastocytosis (AdvSM), SM With an Associated Hematologic Tumor (SM-AHN), Mast Cell Leukemia (MCL) Trial in

Recruiting
  • Advanced Systemic Mastocytosis (AdvSM)
  • +3 more
  • CGT9486 tablets
  • Duarte, California
  • +10 more
Jul 8, 2022

Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Systemic Mastocytosis With an Associated Hematological Tumor

Approved for marketing
  • Advanced Systemic Mastocytosis
  • +3 more
  • (no location specified)
Oct 5, 2021

Avapritinib Versus Best Available Therapy in Patients With AdvSM

Completed
  • Advanced Systemic Mastocytosis
  • +3 more
    • Palo Alto, California
    • +5 more
    Dec 17, 2021

    Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Systemic Mastocytosis With an Associated Hematologic Tumor

    Active, not recruiting
    • Advanced Systemic Mastocytosis
    • +3 more
    • Stanford, California
    • +31 more
    Mar 25, 2022

    Respiratory Disease, Allergic Diseases and/or Mast Cell

    Not yet recruiting
    • Allergic Diseases
    • +2 more
      • Toulouse, France
        Laurent GUILLEMINAULT
      Sep 7, 2023

      Mast Cell Activation Syndrome in EDS With Digestive Disorders

      Recruiting
      • Ehlers Danlos Hypermobile Syndrome
      • Determine the presence of mast cell activation syndrome
      • Lille, Nord, France
        Saint-Vincent-de-Paul hospital
      Jan 10, 2023

      Acute Undifferentiated Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With

      Completed
      • Acute Undifferentiated Leukemia
      • +10 more
      • bioelectric impedance analysis
      • Winston-Salem, North Carolina
        Comprehensive Cancer Center of Wake Forest University
      Jul 30, 2020

      Study of Mast Cell Precursors

      Completed
      • Mastocytosis
      • Healthy Volunteer
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Nov 4, 2022

        Study of Factors Regulating Mast Cell Proliferation

        Recruiting
        • Mastocytosis
        • +3 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Feb 2, 2023

          Mast Cell Activation Disease, Mast Cell Activation Syndrome, Mast Cell Disease Trial in Poitiers (Ophthalmological examination)

          Recruiting
          • Mast Cell Activation Disease
          • +3 more
          • Ophthalmological examination
          • Poitiers, Nouvelle Aquitaine, France
            Masson Regnault
          Apr 12, 2022

          (PROSPECTOR) Screening Study Evaluating Prevalence of KIT D816V

          Recruiting
          • Systemic Mast Cell Activation
          • KIT D816V Mutation
          • Screening
          • Boston, Massachusetts
          • +1 more
          May 5, 2022

          Serum Mast Cell Tryptase Levels to Arthrofibrosis Rates Among

          Active, not recruiting
          • Knee Osteoarthritis
          • +2 more
            • Rochester, Minnesota
              Mayo Clinic
            Jul 27, 2022

            Food Allergy Trial in Dublin, London (Intranasal food challenge, Mast cell activation test)

            Enrolling by invitation
            • Food Allergy
            • Intranasal food challenge
            • Mast cell activation test
            • Dublin, Ireland
            • +1 more
            Oct 18, 2023

            Mast Cell Activation Syndrome Trial in Weldon Spring, Toulouse (Masitinib 4.5 mg/kg/day, Placebo, Best supportive care)

            Recruiting
            • Mast Cell Activation Syndrome
            • Masitinib 4.5 mg/kg/day
            • +3 more
            • Weldon Spring, Missouri
            • +1 more
            Jul 18, 2022

            T Lymphoblastic Leukemia/Lymphoma Trial in Hangzhou (Chidamide)

            Recruiting
            • T Lymphoblastic Leukemia/Lymphoma
            • Hangzhou, Zhejiang, China
              The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
            Aug 7, 2023

            Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

            Not yet recruiting
            • Acute Lymphoblastic Leukemia
            • +6 more
            • Miltenyi CliniMACS Prodigy ® system
            • (no location specified)
            Mar 23, 2023

            B-cell Acute Lymphoblastic Leukemia Trial in Hefei (QH103 Cell Injection, Fludarabine, Cyclophosphamide)

            Recruiting
            • B-cell Acute Lymphoblastic Leukemia
            • QH103 Cell Injection
            • +2 more
            • Hefei, Anhui, China
              Anhui Provincial Hospital
            Sep 21, 2023

            B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)

            Recruiting
            • B-Cell Lymphoblastic Leukemia
            • Acute Lymphoblastic Leukemia
            • Tampa, Florida
              Moffitt Cancer Center
            Nov 28, 2023

            Hairy Cell Leukemia Patients

            Not yet recruiting
            • Hairy Cell Leukemia
              • (no location specified)
              May 5, 2023

              Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

              Recruiting
              • Acute Myeloid Leukemia
              • +3 more
              • CD123 targeted CAR-NK cells
              • Taiyuan, Shanxi, China
                Shanxi Bethune Hospital
              Aug 28, 2023

              Mast Cell Activation Syndrome, Mast Cell Activation Disorder Idiopathic Trial in Weldon Spring, New York, Toronto (FSD201,

              Recruiting
              • Mast Cell Activation Syndrome
              • Mast Cell Activation Disorder Idiopathic
              • Weldon Spring, Missouri
              • +2 more
              Jan 26, 2023

              Extranodal NK T Cell Lymphoma, NK-Cell Leukemia Trial in Xuzhou (Anti-CD56 CAR T)

              Recruiting
              • Extranodal NK T Cell Lymphoma
              • NK-Cell Leukemia
              • Anti-CD56 CAR T
              • Xuzhou, Jiangsu, China
                The Affiliated Hospital of Xuzhou Medical University
              Jul 10, 2023

              B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

              Recruiting
              • B-cell Acute Lymphoblastic Leukemia
              • +2 more
              • CD19/CD22-bispecific CAR-T cells
              • Beijing, Beijing, China
                Liang Wang
              Oct 7, 2023